Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging “early myeloma”
After decades of virtually no progress, multiple myeloma survival has improved significantly in the last 10 years. Indeed, multiple myeloma has perhaps seen more remarkable progress in treatment and patient outcomes than any other cancer during the last decade. Despite significant limitations, conve...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 Jan 2013
|
| In: |
Leukemia and lymphoma
Year: 2013, Jahrgang: 54, Heft: 7, Pages: 1355-1363 |
| ISSN: | 1029-2403 |
| DOI: | 10.3109/10428194.2012.740559 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3109/10428194.2012.740559
|
| Verfasserangaben: | Jens Hillengass, Ola Landgren |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1758405856 | ||
| 003 | DE-627 | ||
| 005 | 20230427100816.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210525s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3109/10428194.2012.740559 |2 doi | |
| 035 | |a (DE-627)1758405856 | ||
| 035 | |a (DE-599)KXP1758405856 | ||
| 035 | |a (OCoLC)1341413736 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hillengaß, Jens |d 1974- |e VerfasserIn |0 (DE-588)124918549 |0 (DE-627)368073823 |0 (DE-576)294568298 |4 aut | |
| 245 | 1 | 0 | |a Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders |b imaging “early myeloma” |c Jens Hillengass, Ola Landgren |
| 264 | 1 | |c 28 Jan 2013 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.05.2021 | ||
| 520 | |a After decades of virtually no progress, multiple myeloma survival has improved significantly in the last 10 years. Indeed, multiple myeloma has perhaps seen more remarkable progress in treatment and patient outcomes than any other cancer during the last decade. Despite significant limitations, conventional radiological skeletal survey still remains the gold standard to rule out bone disease in patients with monoclonal plasma cell diseases. This is even more remarkable, as myeloma is actually a disease of the bone marrow and bone destruction is a secondary complication of advanced disease. Novel imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) allow morphological and functional characterization including information on disease distribution (bone marrow, bone and extramedullary disease), disease activity and minimal residual disease after given therapy. The present review summarizes data on novel imaging techniques and discusses their clinical value and future opportunities for patients with monoclonal plasma cell diseases. | ||
| 650 | 4 | |a early myeloma | |
| 650 | 4 | |a imaging | |
| 650 | 4 | |a MRI | |
| 650 | 4 | |a Multiple myeloma | |
| 650 | 4 | |a PET/CT | |
| 650 | 4 | |a whole-body PET/MRI | |
| 700 | 1 | |a Landgren, Ola |e VerfasserIn |0 (DE-588)1234003694 |0 (DE-627)1758451033 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia and lymphoma |d London [u.a.] : Taylor & Francis Group, 1989 |g 54(2013), 7, Seite 1355-1363 |h Online-Ressource |w (DE-627)324746237 |w (DE-600)2030637-4 |w (DE-576)099718170 |x 1029-2403 |7 nnas |a Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders imaging “early myeloma” |
| 773 | 1 | 8 | |g volume:54 |g year:2013 |g number:7 |g pages:1355-1363 |g extent:9 |a Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders imaging “early myeloma” |
| 856 | 4 | 0 | |u https://doi.org/10.3109/10428194.2012.740559 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210525 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 124918549 |a Hillengaß, Jens |m 124918549:Hillengaß, Jens |d 910000 |d 910100 |e 910000PH124918549 |e 910100PH124918549 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1758405856 |e 3930661403 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title_sort":"Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders","title":"Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders","subtitle":"imaging “early myeloma”"}],"person":[{"given":"Jens","role":"aut","display":"Hillengaß, Jens","family":"Hillengaß"},{"family":"Landgren","display":"Landgren, Ola","role":"aut","given":"Ola"}],"name":{"displayForm":["Jens Hillengass, Ola Landgren"]},"note":["Gesehen am 25.05.2021"],"relHost":[{"recId":"324746237","origin":[{"publisher":"Taylor & Francis Group ; Informa Healthcare","dateIssuedDisp":"1989-","dateIssuedKey":"1989","publisherPlace":"London [u.a.] ; London [u.a.]"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders imaging “early myeloma”Leukemia and lymphoma","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1029-2403"],"zdb":["2030637-4"],"eki":["324746237"]},"note":["Gesehen am 08.09.15"],"pubHistory":["1.1989/90 -"],"title":[{"title_sort":"Leukemia and lymphoma","title":"Leukemia and lymphoma"}],"language":["eng"],"part":{"volume":"54","text":"54(2013), 7, Seite 1355-1363","year":"2013","extent":"9","pages":"1355-1363","issue":"7"}}],"physDesc":[{"extent":"9 S."}],"id":{"eki":["1758405856"],"doi":["10.3109/10428194.2012.740559"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"28 Jan 2013","dateIssuedKey":"2013"}],"recId":"1758405856"} | ||
| SRT | |a HILLENGASSCHALLENGES2820 | ||